Physician

Matthew Ryan Clark, M.D.

According to 2025 Medicare claims, Matthew Clark, M.D. (NPI: 1194162230) practices dermatology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from York, SC. This provider's primary affiliated billing organization is DERMATOLOGIC SURGERY OF THE CAROLINAS LLC (NPI: 1790961670; TIN: 223864190) and primary practice location at 29732-1091.

Clark's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 538 traditional Medicare patients, billed 2,045 HCPCS/CPT codes, and received $492,859 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 299 prescription claims across 221 beneficiaries totaling $145,989 in drug costs, led by Erivedge (Vismodegib). 2023 DME data shows 12 claims. Open Payments data shows 5 records totaling $99. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $54,244 to $492,859. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $151,037 to $145,989. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	97	280	$54,244
2019	375	1,327	$246,836
2020	253	1,512	$132,254
2021	323	1,480	$163,397
2022	389	1,987	$204,376
2023	490	1,933	$233,143
2024	538	2,045	$492,859

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	125	333	$151,037
2016	142	367	$125,526
2017	176	326	$110,680
2018	144	223	$11,269
2019	185	331	$9,950
2020	170	369	$21,847
2021	158	333	$16,570
2022	176	384	$24,935
2023	162	306	$56,044
2024	221	299	$145,989

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$362
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	367	453	$419
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	161	243	$298
12032	Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm	74	79	$180
12052	Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm	101	106	$117
99202	New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more	141	141	$50

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erivedge	Vismodegib	15	390	$140,675
Doxycycline Hyclate	Doxycycline Hyclate	130	837	$580
Cephalexin	Cephalexin	65	314	$152
Mupirocin	Mupirocin	25	338	$110

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$99	SUN PHARMACEUTICAL INDUSTRIES INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Ryan Clark, M.D.?

Tedicare shows public-source Medicare data for Matthew Ryan Clark, M.D. (NPI 1194162230), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Ryan Clark, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Ryan Clark, M.D.?

Matthew Ryan Clark, M.D. is linked to DERMATOLOGIC SURGERY OF THE CAROLINAS LLC (billing NPI 1790961670) in the available physician profile data.

Does Matthew Ryan Clark, M.D. have Open Payments data?

Matthew Ryan Clark, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.